We are currently recruiting participants for the following clinical and non-treatment studies. Each study has age and other requirements and certain clinical exclusions. One advantage of participation is that subjects receive treatment that is free of charge and confidential.  Some studies even provide payment to participants. 

Current Studies
(please select the appropriate heading to learn more about the treatment or non-treatment studies) 
ALCOHOL TREATMENT STUDIES
COCAINE & METHAMPHETAMINE TREATMENT STUDIES
NON-TREATMENT STUDIES

If you are interested in any of these studies, please call the telephone number listed for that study. 

 More information on Clinical Trials at MUSC 

Clinical Trial Name: Adolescent Alcohol Treatment
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Deborah Deas, MD, MPH
Project Coordinator: Natalie Johnson, MA
Contact Person: Natalie Johnson, MA
Contact Number: 876-5070
Study Medications: Naltrexone or Placebo
Therapy: 12 weeks, after twelve week treatment phase, participants will return to the site at 6, 9, and 12 months for follow-up assessments.
Age Requirement: 15-25

Clinical Trial Name: An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Raymond Anton, MD
Project Coordinator: Pat Latham, RN, PhD, CS or Alicia Baros, PhD
Contact Person: Pat Latham, RN, PhD, CS or Alicia Baros, PhD
Contact Number: 792-2727 or 792-1230 or 792-0073
Study Medications: Naltrexone/Placebo, Naltrexone/Aripiprazole, or Placebo/Placebo
Therapy: Individual Medical Management Sessions over 16 weeks
Age Requirement: 18-70

Clinical Trial Name: A Phase 2 Study of LY2196044 Compared with Placebo in the Treatment of Alcohol Dependence
Funding Source: Eli Lilly and Company
Principal Investigator: Raymond Anton, MD
Project Coordinator: Pat Latham, RN, PhD, CS or Alicia Baros, PhD
Contact Person: Pat Latham, RN, PhD, CS or Alicia Baros, PhD
Contact Number: 792-2727 or 792-1230 or 792-0073
Study Medications: LY2196044/Placebo
Therapy: Individual Medical Management Sessions over 16 weeks
Age Requirement: 21-65

Clinical Trial Name: Modafinil and CBT for Cocaine Addiction
Funding Source: National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert Malcolm, MD
Research Assistant: Kelley Barnes, BA
Contact Person: Melissa Corley, MA
Contact Number: 792-2727
Study Medications: Modafinil or Placebo
Therapy: 8 weekly sessions of Cognitive Behavioral Therapy (CBT)
Frequency of visits: Tri-weekly visits, 1-2 week screening period, 8 week treatment period and 2 follow-up visits.
Age Requirement: 18-65

Clinical Trial Name: A Controlled Trial of N-Acetylcysteine for the Treatment of Cocaine Dependence
Funding Source: National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert Malcolm, MD
Project Coordinator: Kristi Huebner, MPH
Contact Person: Melissa Corley, MA
Contact Number: 792-2727
Study Medications: N-Acetylcysteine or Placebo
Therapy: Cognitive Behavioral Therapy (CBT)
Frequency of visits: Tri-weekly visits
Age Requirement: 18-65  

disclaimer